ID SPTN5_HUMAN Reviewed; 3674 AA. AC Q9NRC6; DT 16-NOV-2001, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2014, sequence version 2. DT 27-MAR-2024, entry version 185. DE RecName: Full=Spectrin beta chain, non-erythrocytic 5; DE AltName: Full=Beta-V spectrin; GN Name=SPTBN5; Synonyms=BSPECV, HUBSPECV, HUSPECV; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Cerebellum, Retina, and Spinal cord; RX PubMed=10764729; DOI=10.1074/jbc.c000159200; RA Stabach P.R., Morrow J.S.; RT "Identification and characterization of beta V spectrin, a mammalian RT ortholog of Drosophila beta H spectrin."; RL J. Biol. Chem. 275:21385-21395(2000). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16572171; DOI=10.1038/nature04601; RA Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K., RA Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K., RA FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N., RA Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S., RA Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K., RA DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J., RA Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E., RA Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B., RA Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R., RA O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B., RA Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S., RA Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.; RT "Analysis of the DNA sequence and duplication history of human chromosome RT 15."; RL Nature 440:671-675(2006). RN [3] RP INTERACTION WITH TRPC4. RX PubMed=18048348; DOI=10.1074/jbc.m709729200; RA Odell A.F., Van Helden D.F., Scott J.L.; RT "The spectrin cytoskeleton influences the surface expression and activation RT of human transient receptor potential channel 4 channels."; RL J. Biol. Chem. 283:4395-4407(2008). CC -!- SUBUNIT: Probably associates with an alpha chain. Interacts (via C- CC terminus) with TRPC4. {ECO:0000269|PubMed:18048348}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Note=Detected CC prominently in the outer segments of photoreceptor rods and cones and CC in the basolateral membrane and cytosol of gastric epithelial cells. CC -!- TISSUE SPECIFICITY: Expressed at very low levels in many tissues, with CC strongest expression in cerebellum, spinal cord, stomach, pituitary CC gland, liver, pancreas, salivary gland, kidney, bladder, and heart. CC -!- SIMILARITY: Belongs to the spectrin family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF233523; AAF65317.1; -; mRNA. DR EMBL; AC020659; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS61599.1; -. DR RefSeq; NP_057726.4; NM_016642.3. DR SMR; Q9NRC6; -. DR BioGRID; 119479; 14. DR IntAct; Q9NRC6; 7. DR STRING; 9606.ENSP00000317790; -. DR iPTMnet; Q9NRC6; -. DR PhosphoSitePlus; Q9NRC6; -. DR BioMuta; SPTBN5; -. DR DMDM; 17369320; -. DR EPD; Q9NRC6; -. DR jPOST; Q9NRC6; -. DR MassIVE; Q9NRC6; -. DR PaxDb; 9606-ENSP00000317790; -. DR PeptideAtlas; Q9NRC6; -. DR ProteomicsDB; 82333; -. DR Antibodypedia; 57995; 72 antibodies from 15 providers. DR DNASU; 51332; -. DR Ensembl; ENST00000320955.8; ENSP00000317790.6; ENSG00000137877.10. DR GeneID; 51332; -. DR KEGG; hsa:51332; -. DR MANE-Select; ENST00000320955.8; ENSP00000317790.6; NM_016642.4; NP_057726.4. DR UCSC; uc001zos.5; human. DR AGR; HGNC:15680; -. DR CTD; 51332; -. DR DisGeNET; 51332; -. DR GeneCards; SPTBN5; -. DR HGNC; HGNC:15680; SPTBN5. DR HPA; ENSG00000137877; Group enriched (brain, retina). DR MIM; 605916; gene. DR neXtProt; NX_Q9NRC6; -. DR OpenTargets; ENSG00000137877; -. DR PharmGKB; PA38020; -. DR VEuPathDB; HostDB:ENSG00000137877; -. DR eggNOG; KOG0517; Eukaryota. DR GeneTree; ENSGT00940000161549; -. DR HOGENOM; CLU_000146_3_1_1; -. DR InParanoid; Q9NRC6; -. DR OMA; WANEMHA; -. DR OrthoDB; 2872403at2759; -. DR PhylomeDB; Q9NRC6; -. DR TreeFam; TF313446; -. DR PathwayCommons; Q9NRC6; -. DR Reactome; R-HSA-375165; NCAM signaling for neurite out-growth. DR Reactome; R-HSA-445095; Interaction between L1 and Ankyrins. DR Reactome; R-HSA-5673001; RAF/MAP kinase cascade. DR Reactome; R-HSA-6807878; COPI-mediated anterograde transport. DR SignaLink; Q9NRC6; -. DR BioGRID-ORCS; 51332; 18 hits in 1117 CRISPR screens. DR ChiTaRS; SPTBN5; human. DR GeneWiki; SPTBN5; -. DR GenomeRNAi; 51332; -. DR Pharos; Q9NRC6; Tbio. DR PRO; PR:Q9NRC6; -. DR Proteomes; UP000005640; Chromosome 15. DR RNAct; Q9NRC6; Protein. DR Bgee; ENSG00000137877; Expressed in sural nerve and 103 other cell types or tissues. DR GO; GO:0045179; C:apical cortex; IEA:Ensembl. DR GO; GO:0030054; C:cell junction; IBA:GO_Central. DR GO; GO:0042995; C:cell projection; IBA:GO_Central. DR GO; GO:0030864; C:cortical actin cytoskeleton; IBA:GO_Central. DR GO; GO:0005737; C:cytoplasm; IDA:MGI. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0016020; C:membrane; NAS:UniProtKB. DR GO; GO:0005875; C:microtubule associated complex; IEA:Ensembl. DR GO; GO:0032391; C:photoreceptor connecting cilium; IDA:MGI. DR GO; GO:0097381; C:photoreceptor disc membrane; IDA:MGI. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0008091; C:spectrin; NAS:UniProtKB. DR GO; GO:0003779; F:actin binding; NAS:UniProtKB. DR GO; GO:0051015; F:actin filament binding; IBA:GO_Central. DR GO; GO:0034452; F:dynactin binding; IDA:MGI. DR GO; GO:0045505; F:dynein intermediate chain binding; IDA:MGI. DR GO; GO:0042802; F:identical protein binding; IPI:MGI. DR GO; GO:0019894; F:kinesin binding; IDA:MGI. DR GO; GO:0032029; F:myosin tail binding; IDA:MGI. DR GO; GO:0002046; F:opsin binding; IEA:Ensembl. DR GO; GO:0043621; F:protein self-association; IDA:MGI. DR GO; GO:0030507; F:spectrin binding; IDA:MGI. DR GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central. DR GO; GO:0051693; P:actin filament capping; IEA:UniProtKB-KW. DR GO; GO:0007030; P:Golgi organization; IMP:MGI. DR GO; GO:0007041; P:lysosomal transport; IMP:MGI. DR CDD; cd21247; CH_SPTBN5_rpt1; 1. DR CDD; cd21249; CH_SPTBN5_rpt2; 1. DR CDD; cd00176; SPEC; 16. DR Gene3D; 1.20.58.60; -; 22. DR Gene3D; 1.10.418.10; Calponin-like domain; 2. DR Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1. DR InterPro; IPR001589; Actinin_actin-bd_CS. DR InterPro; IPR001715; CH_dom. DR InterPro; IPR036872; CH_dom_sf. DR InterPro; IPR011993; PH-like_dom_sf. DR InterPro; IPR001849; PH_domain. DR InterPro; IPR018159; Spectrin/alpha-actinin. DR InterPro; IPR002017; Spectrin_repeat. DR PANTHER; PTHR11915:SF435; SPECTRIN BETA CHAIN, NON-ERYTHROCYTIC 5; 1. DR PANTHER; PTHR11915; SPECTRIN/FILAMIN RELATED CYTOSKELETAL PROTEIN; 1. DR Pfam; PF00307; CH; 2. DR Pfam; PF00169; PH; 1. DR Pfam; PF00435; Spectrin; 27. DR SMART; SM00033; CH; 2. DR SMART; SM00233; PH; 1. DR SMART; SM00150; SPEC; 30. DR SUPFAM; SSF47576; Calponin-homology domain, CH-domain; 1. DR SUPFAM; SSF50729; PH domain-like; 1. DR SUPFAM; SSF46966; Spectrin repeat; 23. DR PROSITE; PS00019; ACTININ_1; 1. DR PROSITE; PS00020; ACTININ_2; 1. DR PROSITE; PS50021; CH; 2. DR PROSITE; PS50003; PH_DOMAIN; 1. DR Genevisible; Q9NRC6; HS. PE 1: Evidence at protein level; KW Actin capping; Actin-binding; Cytoplasm; Cytoskeleton; Reference proteome; KW Repeat. FT CHAIN 1..3674 FT /note="Spectrin beta chain, non-erythrocytic 5" FT /id="PRO_0000073466" FT DOMAIN 54..159 FT /note="Calponin-homology (CH) 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00044" FT DOMAIN 177..282 FT /note="Calponin-homology (CH) 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00044" FT REPEAT 307..416 FT /note="Spectrin 1" FT /evidence="ECO:0000255" FT REPEAT 428..529 FT /note="Spectrin 2" FT /evidence="ECO:0000255" FT REPEAT 642..742 FT /note="Spectrin 3" FT /evidence="ECO:0000255" FT REPEAT 747..810 FT /note="Spectrin 4" FT /evidence="ECO:0000255" FT REPEAT 900..996 FT /note="Spectrin 5" FT /evidence="ECO:0000255" FT REPEAT 1103..1206 FT /note="Spectrin 6" FT /evidence="ECO:0000255" FT REPEAT 1209..1311 FT /note="Spectrin 7" FT /evidence="ECO:0000255" FT REPEAT 1315..1417 FT /note="Spectrin 8" FT /evidence="ECO:0000255" FT REPEAT 1521..1624 FT /note="Spectrin 9" FT /evidence="ECO:0000255" FT REPEAT 1628..1727 FT /note="Spectrin 10" FT /evidence="ECO:0000255" FT REPEAT 1731..1835 FT /note="Spectrin 11" FT /evidence="ECO:0000255" FT REPEAT 1842..1940 FT /note="Spectrin 12" FT /evidence="ECO:0000255" FT REPEAT 1944..2046 FT /note="Spectrin 13" FT /evidence="ECO:0000255" FT REPEAT 2052..2146 FT /note="Spectrin 14" FT /evidence="ECO:0000255" FT REPEAT 2150..2253 FT /note="Spectrin 15" FT /evidence="ECO:0000255" FT REPEAT 2256..2361 FT /note="Spectrin 16" FT /evidence="ECO:0000255" FT REPEAT 2366..2467 FT /note="Spectrin 17" FT /evidence="ECO:0000255" FT REPEAT 2471..2574 FT /note="Spectrin 18" FT /evidence="ECO:0000255" FT REPEAT 2577..2680 FT /note="Spectrin 19" FT /evidence="ECO:0000255" FT REPEAT 2683..2784 FT /note="Spectrin 20" FT /evidence="ECO:0000255" FT REPEAT 2791..2890 FT /note="Spectrin 21" FT /evidence="ECO:0000255" FT REPEAT 2894..2997 FT /note="Spectrin 22" FT /evidence="ECO:0000255" FT REPEAT 3000..3103 FT /note="Spectrin 23" FT /evidence="ECO:0000255" FT REPEAT 3106..3209 FT /note="Spectrin 24" FT /evidence="ECO:0000255" FT REPEAT 3213..3311 FT /note="Spectrin 25" FT /evidence="ECO:0000255" FT REPEAT 3318..3415 FT /note="Spectrin 26" FT /evidence="ECO:0000255" FT REPEAT 3422..3488 FT /note="Spectrin 27" FT /evidence="ECO:0000255" FT DOMAIN 3533..3641 FT /note="PH" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00145" FT REGION 1..279 FT /note="Actin-binding" FT REGION 1..37 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1441..1469 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1453..1467 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT VARIANT 1345 FT /note="R -> H (in dbSNP:rs2290559)" FT /id="VAR_022050" FT VARIANT 1367 FT /note="R -> T (in dbSNP:rs2290558)" FT /id="VAR_024395" FT VARIANT 2862 FT /note="Q -> R (in dbSNP:rs1456235)" FT /id="VAR_024396" FT VARIANT 3275 FT /note="A -> G (in dbSNP:rs1197660)" FT /id="VAR_024397" FT CONFLICT 433 FT /note="H -> R (in Ref. 1; AAF65317)" FT /evidence="ECO:0000305" FT CONFLICT 1035 FT /note="C -> R (in Ref. 1; AAF65317)" FT /evidence="ECO:0000305" FT CONFLICT 1053 FT /note="H -> Y (in Ref. 1; AAF65317)" FT /evidence="ECO:0000305" FT CONFLICT 3564 FT /note="N -> T (in Ref. 1; AAF65317)" FT /evidence="ECO:0000305" SQ SEQUENCE 3674 AA; 416750 MW; 83D1F94ADE670E13 CRC64; MAGQPHSPRE LLGAAGHRSR RPSTELRVPP SPSLTMDSQY ETGHIRKLQA RHMQMQEKTF TKWINNVFQC GQAGIKIRNL YTELADGIHL LRLLELISGE ALPPPSRGRL RVHFLENSSR ALAFLRAKVP VPLIGPENIV DGDQTLILGL IWVIILRFQI SHISLDKEEF GASAALLSTK EALLVWCQRK TASYTNVNIT DFSRSWSDGL GFNALIHAHR PDLLDYGSLR PDRPLHNLAF AFLVAEQELG IAQLLDPEDV AAAQPDERSI MTYVSLYYHY CSRLHQGQTV QRRLTKILLQ LQETELLQTQ YEQLVADLLR WIAEKQMQLE ARDFPDSLPA MRQLLAAFTI FRTQEKPPRL QQRGAAEALL FRLQTALQAQ NRRPFLPHEG LGLAELSQCW AGLEWAEAAR SQALQQRLLQ LQRLETLARR FQHKAALRES FLKDAEQVLD QARAPPASLA TVEAAVQRLG MLEAGILPQE GRFQALAEIA DILRQEQYHS WADVARRQEE VTVRWQRLLQ HLQGQRKQVA DMQAVLSLLQ EVEAASHQLE ELQEPARSTA CGQQLAEVVE LLQRHDLLEA QVSAHGAHVS HLAQQTAELD SSLGTSVEVL QAKARTLAQL QQSLVALVRA RRALLEQTLQ RAEFLRNCEE EEAWLKECGQ RVGNAALGRD LSQIAGALQK HKALEAEVHR HQAVCVDLVR RGRDLSARRP PTQPDPGERA EAVQGGWQLL QTRVVGRGAR LQTALLVLQY FADAAEAASW LRERRSSLER ASCGQDQAAA ETLLRRHVRL ERVLRAFAAE LRRLEEQGRA ASARASLFTV NSALSPPGES LRNPGPWSEA SCHPGPGDAW KMALPAEPDP DFDPNTILQT QDHLSQDYES LRALAQLRRA RLEEAMALFG FCSSCGELQL WLEKQTVLLQ RVQPQADTLE VMQLKYENFL TALAVGKGLW AEVSSSAEQL RQRYPGNSTQ IQRQQEELSQ RWGQLEALKR EKAVQLAHSV EVCSFLQECG PTQVQLRDVL LQLEALQPGS SEDTCHALQL AQKKTLVLER RVHFLQSVVV KVEEPGYAES QPLQGQVETL QGLLKQVQEQ VAQRARRQAE TQARQSFLQE SQQLLLWAES VQAQLRSKEV SVDVASAQRL LREHQDLLEE IHLWQERLQQ LDAQSQPMAA LDCPDSQEVP NTLRVLGQQG QELKVLWEQR QQWLQEGLEL QKFGREVDGF TATCANHQAW LHLDNLGEDV REALSLLQQH REFGRLLSTL GPRAEALRAH GEKLVQSQHP AAHTVREQLQ SIQAQWTRLQ GRSEQRRRQL LASLQLQEWK QDVAELMQWM EEKGLMAAHE PSGARRNILQ TLKRHEAAES ELLATRRHVE ALQQVGRELL SRRPCGQEDI QTRLQGLRSK WEALNRKMTE RGDELQQAGQ QEQLLRQLQD AKEQLEQLEG ALQSSETGQD LRSSQRLQKR HQQLESESRT LAAKMAALAS MAHGMAASPA ILEETQKHLR RLELLQGHLA IRGLQLQASV ELHQFCHLSN MELSWVAEHM PHGSPTSYTE CLNGAQSLHR KHKELQVEVK AHQGQVQRVL SSGRSLAASG HPQAQHIVEQ CQELEGHWAE LERACEARAQ CLQQAVTFQQ YFLDVSELEG WVEEKRPLVS SRDYGRDEAA TLRLINKHQA LQEELAIYWS SMEELDQTAQ TLTGPEVPEQ QRVVQERLRE QLRALQELAA TRDRELEGTL RLHEFLREAE DLQGWLASQK QAAKGGESLG EDPEHALHLC TKFAKFQHQV EMGSQRVAAC RLLAESLLER GHSAGPMVRQ RQQDLQTAWS ELWELTQARG HALRDTETTL RVHRDLLEVL TQVQEKATSL PNNVARDLCG LEAQLRSHQG LERELVGTER QLQELLETAG RVQKLCPGPQ AHAVQQRQQA VTQAWAVLQR RMEQRRAQLE RARLLARFRT AVRDYASWAA RVRQDLQVEE SSQEPSSGPL KLSAHQWLRA ELEAREKLWQ QATQLGQQAL LAAGTPTKEV QEELRALQDQ RDQVYQTWAR KQERLQAEQQ EQLFLRECGR LEEILAAQEV SLKTSALGSS VEEVEQLIRK HEVFLKVLTA QDKKEAALRE RLKTLRRPRV RDRLPILLQR RMRVKELAES RGHALHASLL MASFTQAATQ AEDWIQAWAQ QLKEPVPPGD LRDKLKPLLK HQAFEAEVQA HEEVMTSVAK KGEALLAQSH PRAGEVSQRL QGLRKHWEDL RQAMALRGQE LEDRRNFLEF LQRVDLAEAW IQEKEVKMNV GDLGQDLEHC LQLRRRLREF RGNSAGDTVG DACIRSISDL SLQLKNRDPE EVKIICQRRS QLNNRWASFH GNLLRYQQQL EGALEIHVLS RELDNVTKRI QEKEALIQAL DCGKDLESVQ RLLRKHEELE REVHPIQAQV ESLEREVGRL CQRSPEAAHG LRHRQQEVAE SWWQLRSRAQ KRREALDALH QAQKLQAMLQ ELLVSAQRLR AQMDTSPAPR SPVEARRMLE EHQECKAELD SWTDSISLAR STGQQLLTAG HPFSSDIRQV LAGLEQELSS LEGAWQEHQL QLQQALELQL FLSSVEKMER WLCSKEDSLA SEGLWDPLAP MEPLLWKHKM LEWDLEVQAG KISALEATAR GLHQGGHPEA QSALGRCQAM LLRKEALFRQ AGTRRHRLEE LRQLQAFLQD SQEVAAWLRE KNLVALEEGL LDTAMLPAQL QKQQNFQAEL DASMHQQQEL QREGQRLLQG GHPASEAIQE RLEELGALWG ELQDNSQKKV AKLQKACEAL RLRRSMEELE NWLEPIEVEL RAPTVGQALP GVGELLGTQR ELEAAVDKKA RQAEALLGQA QAFVREGHCL AQDVEEQARR LLQRFKSLRE PLQERRTALE ARSLLLKFFR DADEEMAWVQ EKLPLAAAQD YGQSLSAVRH LQEQHQNLES EMSSHEALTR VVLGTGYKLV QAGHFAAHEV AARVQQLEKA MAHLRAEAAR RRLLLQQAQE AQQFLTELLE AGSWLAERGH VLDSEDMGHS AEATQALLRR LEATKRDLEA FSPRIERLQQ TAALLESRKN PESPKVLAQL QAVREAHAEL LRRAEARGHG LQEQLQLHQL ERETLLLDAW LTTKAATAES QDYGQDLEGV KVLEEKFDAF RKEVQSLGQA KVYALRKLAG TLERGAPRRY PHIQAQRSRI EAAWERLDQA IKARTENLAA AHEVHSFQQA AAELQGRMQE KTALMKGEDG GHSLSSVRTL QQQHRRLERE LEAMEKEVAR LQTEACRLGQ LHPAAPGGLA KVQEAWATLQ AKAQERGQWL AQAAQGHAFL GRCQELLAWA QERQELASSE ELAEDVAGAE QLLGQHEELG QEIRECRLQA QDLRQEGQQL VDNSHFMSAE VTECLQELEG RLQELEEAWA LRWQRCAESW GLQKLRQRLE QAEAWLACWE GLLLKPDYGH SVSDVELLLH RHQDLEKLLA AQEEKFAQMQ KTEMEQELLL QPQELKPGRA GSSLTSFQWR PSGHQGLGAQ LAETRDPQDA KGTPTMEGSL EFKQHLLPGG RQPSSSSWDS CRGNLQGSSL SLFLDERMAA EKVASIALLD LTGARCERLR GRHGRKHTFS LRLTSGAEIL FAAPSEEQAE SWWRALGSTA AQSLSPKLKA KPVSSLNECT TKDARPGCLL RSDP //